AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.82%33.750.9%$1145.03m
JNJJohnson & Johnson 0.29%143.270.7%$1079.06m
BMYBristol-Myers Squibb Co. -1.19%59.571.0%$967.54m
MRKMerck & Co., Inc. -1.07%77.880.7%$816.26m
ABBVAbbVie, Inc. -0.03%99.322.3%$785.33m
LLYEli Lilly & Co. 1.42%169.121.1%$695.99m
AZNAstraZeneca Plc 1.35%54.191.2%$290.07m
VXRTVaxart, Inc. -8.12%8.150.0%$286.48m
RPRXRoyalty Pharma Plc 2.06%48.020.1%$226.50m
NVSNovartis AG 0.36%88.120.2%$151.51m
RGENRepligen Corp. 0.92%125.287.2%$117.23m
GSKGlaxoSmithKline Plc 0.84%40.720.2%$112.42m
NVONovo Nordisk A/S 1.25%65.870.1%$94.18m
RETAReata Pharmaceuticals, Inc. 1.52%158.003.4%$82.12m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 8.02%77.860.0%$73.21m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.